Michael Torres
@Mykalt45
Cancer Bio PhD @utswmedcenter. Entrepreneur. CEO @CrossBridgeBio. @ReCodeTX Co-founder & Former VP R&D. EIR @TMCInnovation. @NIH_OITE UGSP scholar. @Artan_bio
Lots of talk about dual-payload ADC recently. Excited for what we’re building at @CrossBridgeBio, especially since we’re ADC through and through. My CSO developed Padcev at Agensys. Our linker tech was developed in house and I brought the inventors in! NHP tox study dosing soon.
Dad daughter weekend at Lost Pines. #twitter instagr.am/p/DMjJw0VMupW/
Congrats to the @ResearchHub team. A sincere project, that cares about scientists in DeSci is rare so great to see them be recognized. Keep in mind most DeSci projects use science as camouflage to do financial crypto acrobatics - without benefit to science or the “mission”.
Assets added to the roadmap today: ResearchCoin (RSC) coinbase.com/blog/increasin…
1/ Our call to action is out in @BloodAdvances! Title speaks for itself. Given concerningly high infection risk with bsAbs in myeloma #MMsm, IVIG/SCIG should be started regardless of any IgG threshold. Global authors & global audience, including insurance & healthcare funders.
I need those Atlas deal economics! High dollars for preclinical. Congrats!
Excited to partner with @Novartis on a novel I&I program borne out of our targeted covalency engine at @matchpointtx Novartis inks deal with covalent medicines biotech Matchpoint for $60M upfront - endpoints.news/novartis-inks-…
Hey DeSci, it's MIRA. The genesis of Molecule's AI systems is here. From Proof-of-Invention to intellectual property tokens, Molecule has always built tools to reshape how science is funded and coordinated. LLMs & AI systems are the next logical layer. MIRA is a…
What “fancy” ADCs are in the pipeline? @thenasheffect reviews the rapidly evolving field of ISACs, DACs, bsADCs and further innovative ways of utilizing the ADC paradigm to selectively deliver anticancer molecules to tumors. Many bumps along the way, a lot of hopes for the future
This is amazing actually - liquid preclinical science available on ethereum. $6M market cap looks priced appropriately!
Keep an eye out on Artan-102 and $vitarna! Latest non-con can be found here: molecule.xyz/ipts/VITARNA
1/ 🚀 Longevity biotech focuses on extending healthy years, not just lifespan Aging populations will cost $7.1T in the US by 2050. One breakthrough - an FDA healthspan label - could reshape medicine and markets. Here’s what’s coming.
Proud to share another significant milestone from our Oncology team: we’ve completed a global, ex-China, licensing agreement with 3SBio Inc. to advance the development of an investigational next-generation bispecific antibody, further reinforcing our commitment to delivering…
Keep an eye out for something new!
Partnering with great people is key for success. The idea for our 351 exchange of Bitcoin for $ASST shares came from our ETF partner @alphaarchitect. Congrats to them on using 351s to seed $AAUS with almost $500M and democratize access to this amazing tax strategy!
A landmark study published in @Nature by @aaronmring et al. has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may profoundly influence how cancer patients respond to immunotherapy. bit.ly/4o4HANS
While a longstanding partnership is ending, the Texas Medical Center says it will be able to offer more space for startups and other commercial ventures. bizjournals.com/houston/news/2…
J&J Innovation to exit Children's National incubator by 2026 - Washington Business Journal bizjournals.com/washington/new…
And yet so hard for some people to do.
A major cheat code in life: Being a pleasure to deal with. Kind when others aren’t. Calm when things go sideways. Reliable under pressure. Intelligence alone is overrated. Be someone who lightens the load for folks around them. People value people who make their lives easier.
Maybe this is a dumb idea, but could immune reset be the killer app for partial reprogramming?
Longevity is no longer confined to labs. It's a full-blown lifestyle industry projected to hit $40B + by 2030. Americans are spending up to $25K/year on longevity clinics. But most of these interventions are off-label, unregulated, and no real data.
My kids asked me what games I used to play on my IPad as a kid. I told them I used to speak into a fan to sound like a robot.
Know some smart folks looking to fundamentally address this! Wild if it works!
“Biotech investing is hope weaponized by science — and heartbreak funded by dilution.” ChatGPT $xbi Straight quote